Skip to main content
. 2017 May 11;8(34):57907–57933. doi: 10.18632/oncotarget.17826

Table 3. A list of AR-signature genes that have AR-binding signals in their 5 kb promoter regions using ChIP-seq data.

Gene AR average C1orf64 CC p value Datasets
*C1orf64 165 1 <0.001 BC Cell lines
*SIDT1 133 0.667 <0.001 TCGA Breast
*F7 58 0.678 <0.001 BC Cell lines
PATZ1 38 >0.05 TCGA Breast
*RHOH 116 0.629 <0.001 BC Cell lines
CCDC125 267 >0.05 TCGA Breast
TBC1D30 119 >0.05 Bos Breast
*SPDEF 51 0.734 <0.001 BC Cell lines
*DOPEY2 230 0.693 <0.001 BC Cell lines
*RHOB 216 0.677 <0.001 BC Cell lines
SLCO2A1 30 >0.05 BC Cell lines
*FOXA1 174 0.721 <0.001 BC Cell lines
*SLC9A2 60 0.809 <0.001 BC Cell lines
PYGO1 27 >0.05 BC Cell lines
*TTC6 174 0.631 <0.001 BC Cell lines
*CREB3L4 27 0.775 <0.001 BC Cell lines
*SLC16A6 839 0.505 0.001 BC Cell lines
*KIAA1324 46 0.727 <0.001 BC Cell lines
*DEGS2 498 0.665 <0.001 BC Cell lines
TRIL 45 >0.05 TCGA Breast
DALRD3 293 NA
*UMODL1 42 0.675 <0.001 BC Cell lines
GSE1 19 >0.05 TCGA Breast
AMBP 333 >0.05 BC Cell lines
*ZG16B 107 0.577 <0.001 TCGA Breast
*CRAT 654 0.42 0.009 BC Cell lines
MVK 46 NA
CACFD1 120 NA
*SLC9A3R1 101 0.659 <0.001 BC Cell lines
*ATP8A1 34 0.664 <0.001 BC Cell lines
*PIM1 44 −0.632 <0.001 BC Cell lines

Average ChIP-seq signal for AR binding, correlation coefficient (CC) between the expression of each signature gene and C1orf64, p value for each CC, and the source of data for CC analysis are shown. BC: breast cancer, NA: not available. Asterisks depict the AR-signature genes that have a detectable AR-binding signal using ChIP-seq and a significant correlation (p<0.01) with C1orf64 expression in breast cancer.